Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5139]

Debate: Challenges and solutions for new treatment options in mUC

Dr. María José Juan Fita, Dr. Bernadett Szabados, Prof. Rafael S. Grajewski, Dr...

Debate: Challenges and solutions for new treatment options in mUC ( Dr. María José Juan Fita, Dr. Bernadett Szabados, Prof. Rafael S. Grajewski, Dr. Diego Teyssonneau )

SIOG 2024: Updates in haematology

Dr Ashley Rosko - The Ohio State University, Columbus, USA

SIOG 2024: Updates in haematology ( Dr Ashley Rosko - The Ohio State University, Columbus, USA )

CDK4/6 inhibitors and endocrine therapy in elderly female patients with...

Dr Renu Ragupathi - University Hospitals Dorset, Bournemouth, UK

CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC ( Dr Renu Ragupathi - University Hospitals Dorset, Bournemouth, UK )

Fracture risk increases following cancer therapies for advanced prostate cancer

Dr Grace Lu-Yao - Thomas Jefferson University, Philadelphia, USA

Fracture risk increases following cancer therapies for advanced prostate cancer ( Dr Grace Lu-Yao - Thomas Jefferson University, Philadelphia, USA )

Unlocking the potential of liquid biopsy applications in personalised care for...

Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer ( Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany )

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Daratumumab-based maintenance regimens show favourable responses in transplant...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Daratumumab-based maintenance regimens show favourable responses in transplant-eligible NDMM ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Optimising benefit-risk and minimising impact on quality of life with BCMA...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Understanding the remaining unmet needs in a post ASCT NDMM setting

Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway

Understanding the remaining unmet needs in a post ASCT NDMM setting ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )

Approaches to risk stratification in high risk myeloma

Dr Irene Ghobrial - Dana-Farber Cancer Institute, Boston, USA

Approaches to risk stratification in high risk myeloma ( Dr Irene Ghobrial - Dana-Farber Cancer Institute, Boston, USA )

Use of bispecifics and CAR T cells in South America

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

Use of bispecifics and CAR T cells in South America ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

Tailored to fit: New approaches in transplant-ineligible NDMM

Prof Xavier Leleu - CHU de Poitiers, Poitiers, France

Tailored to fit: New approaches in transplant-ineligible NDMM ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )

More from ecancer